Purchase Order N0017317P0750
- Not listed
- The Office of Naval Research (ONR) awarded a $4,410 firm fixed-price purchase order to Bio-Synthesis, Inc. on February 24, 2016, for biologicals, with performance completion targeted for March 23, 2016. Bio-Synthesis, Inc., a Hispanic American-owned manufacturer based in Lewisville, Texas, and operating under the trade name Dnaexam, specializes in custom synthesis of advanced biological research materials including peptides, RNA, and nucleic acid products. No set-aside designation was applied to...
- The Office of Naval Research (ONR) awarded a $3,400 purchase order to Bio-Synthesis, Inc., a Hispanic American-owned manufacturer specializing in custom peptide synthesis and advanced biological research materials. The firm fixed price contract, issued on January 15, 2014, with an ultimate completion date of February 5, 2014, was performed at Bio-Synthesis's facility in Lewisville, Texas. No set-aside designation was utilized for this award. Bio-Synthesis, Inc., which operates under the trade...
- The Office of Naval Research (ONR) awarded a $3,655 firm fixed-price purchase order to Bio-Synthesis, Inc. for custom peptides, with an ultimate completion date of April 25, 2013. The award, issued on March 26, 2013, was not structured under any set-aside designation. Bio-Synthesis, Inc., a Hispanic American-owned manufacturer based in Lewisville, Texas, specializes in advanced biological research materials and custom synthesis services, including peptide and nucleic acid production for...
- The Office of Naval Research awarded a $4,375 purchase order to Bio-Synthesis, Inc. for custom CECA peptide synthesis services. The contract, issued on May 29, 2014, with an ultimate completion date of June 23, 2014, represents a firm fixed-price engagement with no set-aside designation. Bio-Synthesis, Inc., a Hispanic American-owned manufacturer based in Lewisville, Texas, and operating under the trade name Dnaexam, specializes in advanced biological research materials and custom molecular...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Bio-Synthesis, Inc. for chemical RNA ubermers and RNA transcription synthesis, valued at $5,210.00, with an award date of March 21, 2018 and completion date of March 20, 2019. Work is performed in Lewisville, Texas. Bio-Synthesis, Inc. is a Hispanic American-owned manufacturer of biological research materials.</p>
- This federal contract award, with the ID HHSN272201200589P, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Bio-Synthesis, Inc. (doing business as Dnaexam), a for-profit, Hispanic American-owned manufacturer. The contract, with a firm fixed price of $5,565.00, is for the delivery of drugs and biologicals. The contract does not have a set-aside designation and was awarded on July 18, 2012, with a...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Bio-Synthesis, Inc., a Hispanic American-owned small business. The contract is for custom peptide synthesis services, with a ceiling value of $3,259.00 and an ultimate completion date of February 25, 2015. The contract was awarded on February 18, 2015 and did not use a set-aside....
- This is a $10,585.00 firm fixed price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency, to Bio-Synthesis, Inc., a Hispanic American-owned manufacturer of goods. The contract is for the delivery of stapled NIX-derived peptides with derivatized N-termini to support the agency's ongoing study of the NIX/WIPI protein interaction, which began in March 2023. The award does not utilize a set-aside designation, and the ultimate completion date is June 24, 2025.
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Bio-Synthesis, Inc. (doing business as Dnaexam) for the custom synthesis of oligonucleotides. The contract has a ceiling value of $29,580.00 and an ultimate completion date of February 28, 2010. The agency indicates a high demand and usage level for these oligonucleotides, particularly for a recombinant vaccine project against...
- The U.S. Office of Naval Research (ONR) awarded a $8,995.00 firm fixed-price purchase order to Biolytic Lab Performance Inc., a veteran-owned for-profit organization, for the repair of equipment. The contract has a completion date of September 9, 2024 and was not set aside for any specific business type. Biolytic Lab Performance Inc. is a provider of DNA synthesis solutions, including oligonucleotide synthesizers, chemistry instruments, and laboratory equipment, to various federal agencies...
The Office of Naval Research awarded a firm fixed-price purchase order valued at $13,220 to Bio-Synthesis, Inc. (doing business as Dnaexam) on February 6, 2017, with an ultimate completion date of March 8, 2017. The contract, registered under PR# 69-4143-17, was issued without a set-aside designation and covers biologicals to be delivered to Lewisville, Texas. Bio-Synthesis, Inc., a Hispanic American-owned manufacturer of specialized biological research materials headquartered in Lewisville, brings extensive expertise in custom synthesis services, particularly in peptide, RNA, and nucleic acid production for federal research institutions. Bio-Synthesis, Inc. has established itself as a reliable supplier of advanced molecular and genetic research products to prominent federal agencies including the National Heart Lung and Blood Institute, National Institute of Allergy and Infectious Diseases, and National Institute on Drug Abuse. The company's contract history demonstrates technical competency in delivering precise, high-quality custom research materials such as stapled peptides, custom RNA synthesis, and specialized oligos. This purchase order represents routine procurement of biological materials to support the Navy's research objectives, consistent with the company's demonstrated capabilities in the biomedical research sector.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.2k | 2/5/17 |